Laxity of Skin

Case 16

thermiva case studyPatient in her early 50s complains of vulvar laxity, vaginal dryness, repetitive urinary and vaginal infections, and a leaky bladder. She underwent ThermiVa treatments and was placed on vaginal estrogen therapy which resolved her symptoms completely.

Results: Her stress incontinence and overactive bladder and nocturia were eliminated.

  Before ThermiVa Treatment

Before ThermiVa Treatment

after-thermiva treatment 1
After ThermiVa Treatment 1

after-thermiva treatment 2
After ThermiVa Treatment 2

after-thermiva treatment 3
After ThermiVa Treatment 3

CASE: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16


ThermiVa RF is FDA cleared for dermatological and general surgical procedures for electrocoagulation and hemostasis.

ThermiVa has FDA Approval for Dermatologic Conditions, Surgery, Surgical Nerve Ablation.  Examples of dermatologic conditions include loose skin, dry skin, thin skin, insensitive skin.  ThermiVa has a CE Mark and EU Approved for Vulvovaginal Laxity or for treatment of loose tissues of the vulva and vagina.

ThermiVa does not have FDA or EU approval for incontinence or the leaky bladder or rectum, atrophy or vaginal dryness, prolapse or fallen bladder/rectum, or orgasmic dysfunction.